Zobrazeno 1 - 10
of 257
pro vyhledávání: '"Maura N, Dickler"'
Autor:
José Baselga, Andrew Koustenis, Martin Frenzel, Denise A. Yardley, Esther Zamora, Joyce O'Shaughnessy, Clifford A. Hudis, Hans Wildiers, Debra Patt, Véronique Diéras, Javier Cortés, Hope S. Rugo, Sara M. Tolaney, Maura N. Dickler
Supplemental Figure 1. Study Design and Patient Disposition Supplemental Figure 2. Change in serum creatinine by visit Supplemental Figure 3. Change in blood urea nitrogen (BUN) by visit Supplemental Figure 4. Maximum observed value in cystatin C by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c79c5a83b7a7daad1f4634068fd8b447
https://doi.org/10.1158/1078-0432.22468395
https://doi.org/10.1158/1078-0432.22468395
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Study disposition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54688aa6bdc19b53f7e66ca2401b9476
https://doi.org/10.1158/1078-0432.22470125
https://doi.org/10.1158/1078-0432.22470125
Autor:
José Baselga, Andrew Koustenis, Martin Frenzel, Denise A. Yardley, Esther Zamora, Joyce O'Shaughnessy, Clifford A. Hudis, Hans Wildiers, Debra Patt, Véronique Diéras, Javier Cortés, Hope S. Rugo, Sara M. Tolaney, Maura N. Dickler
Supplemental Table 1. Post-discontinuation therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9935dfa4ebd65bb05f8542cd874cec7
https://doi.org/10.1158/1078-0432.22468389
https://doi.org/10.1158/1078-0432.22468389
Autor:
José Baselga, Andrew Koustenis, Martin Frenzel, Denise A. Yardley, Esther Zamora, Joyce O'Shaughnessy, Clifford A. Hudis, Hans Wildiers, Debra Patt, Véronique Diéras, Javier Cortés, Hope S. Rugo, Sara M. Tolaney, Maura N. Dickler
Purpose: The phase II MONARCH 1 study was designed to evaluate the single-agent activity and adverse event (AE) profile of abemaciclib, a selective inhibitor of CDK4 and CDK6, in women with refractory hormone receptor–positive (HR+), HER2− metast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::034b8161c60a47be698f6b30bb02f65c
https://doi.org/10.1158/1078-0432.c.6526920
https://doi.org/10.1158/1078-0432.c.6526920
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Participant PIK3CA-mutation central testing results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2863ddcb43ff59658511ba8e4758454e
https://doi.org/10.1158/1078-0432.22470131.v1
https://doi.org/10.1158/1078-0432.22470131.v1
Autor:
Sunil S. Badve, Nancy E. Davidson, Joseph A. Sparano, George W. Sledge, Ann Thor, Sven Müller, Kirsten Vang Nielsen, Tamara N. Shenkier, Edith A. Perez, Melody A. Cobleigh, Maura N. Dickler, Julie R. Gralow, Kathy D. Miller, Guanglong Jiang, Lang Li, Gail Vance, Fei Shen, Milan Radovich, Robert J. Gray, Bryan P. Schneider
PDF file - 121K, Table 1. Supplemental Table 1. Comparison of the Patients Analyzable for VEGFA Amplification to All Patients Enrolled on E2100 Table 2. Estimated Progression Free Survival treatment hazard ratios (arm A vs. arm B) and 95% confidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c84628500a797ceea4c46f6f1b711b2
https://doi.org/10.1158/1078-0432.22449660.v1
https://doi.org/10.1158/1078-0432.22449660.v1
Autor:
Sunil S. Badve, Nancy E. Davidson, Joseph A. Sparano, George W. Sledge, Ann Thor, Sven Müller, Kirsten Vang Nielsen, Tamara N. Shenkier, Edith A. Perez, Melody A. Cobleigh, Maura N. Dickler, Julie R. Gralow, Kathy D. Miller, Guanglong Jiang, Lang Li, Gail Vance, Fei Shen, Milan Radovich, Robert J. Gray, Bryan P. Schneider
Purpose: Clinically validated biomarkers for anti-angiogenesis agents are not available. We have previously reported associations between candidate VEGFA single-nucleotide polymorphisms (SNP) and overall survival (OS) in E2100. The associations betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45f822147b99a3f6e260a798dc86fa91
https://doi.org/10.1158/1078-0432.c.6521718
https://doi.org/10.1158/1078-0432.c.6521718
Autor:
José Baselga, Andrew Koustenis, Martin Frenzel, Denise A. Yardley, Esther Zamora, Joyce O'Shaughnessy, Clifford A. Hudis, Hans Wildiers, Debra Patt, Véronique Diéras, Javier Cortés, Hope S. Rugo, Sara M. Tolaney, Maura N. Dickler
Methods that support the supplemental data provided
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6459561877577139b536e7c67614780e
https://doi.org/10.1158/1078-0432.22468392.v1
https://doi.org/10.1158/1078-0432.22468392.v1
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Purpose: This single-arm, open-label phase II study evaluated the safety and efficacy of taselisib (GDC-0032) plus fulvestrant in postmenopausal women with locally advanced or metastatic HER2-negative, hormone receptor (HR)-positive breast cancer.Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcfa6f15e33353fab87b74f809dce14
https://doi.org/10.1158/1078-0432.c.6527435
https://doi.org/10.1158/1078-0432.c.6527435
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Definition of adverse events of special interest (AESI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cefcb97387728d98ee62316ec97bda0
https://doi.org/10.1158/1078-0432.22470134
https://doi.org/10.1158/1078-0432.22470134